Hemorrhagic Fever, Ebola

Also known as: Ebola Disease / Ebola Virus Infection / Ebola Hemorrhagic Fever / Ebola virus disease -RETIRED- / Ebola virus disease (disorder) / Ebola haemorrhagic fever / Ebola virus disease

DrugDrug NameDrug Description
DB16385AnsuvimabA fully human monoclonal IgG1 antibody directed against the GP1,2 surface protein of Zaire ebolavirus that is an effective treatment for Ebola virus disease.
DB15898AtoltivimabPart of a product containing three monoclonal IgG1κ antibodies directed against the GP1,2 glycoprotein of Zaire ebolavirus. Together, these three antibodies act to neutralize viral particles and to recruit immune effectors for the destruction of both viral particles and infected cells.
DB15899MaftivimabPart of a product containing three monoclonal IgG1κ antibodies directed against the GP1,2 glycoprotein of Zaire ebolavirus. Together, these three antibodies act to neutralize viral particles and to recruit immune effectors for the destruction of both viral particles and infected cells.
DB15483Modified vaccinia ankaraNot Annotated
DB15900OdesivimabPart of a product containing three monoclonal IgG1κ antibodies directed against the GP1,2 glycoprotein of Zaire ebolavirus. Together, these three antibodies act to neutralize viral particles and to recruit immune effectors for the destruction of both viral particles and infected cells.
DrugDrug NamePhaseStatusCount
DB15433AVI-75371Withdrawn1
DB11676Galidesivir1Completed1
DB15483Modified vaccinia ankara1Completed2
DB14556Peracetic acid1 / 2Completed1
DB15483Modified vaccinia ankara3Active Not Recruiting1